Dr. John Öhd
Chief Medical Officer
Dr. Öhd joined Modus at Chief Medical Officer in March 2018 from Medivir AB, where he was CMO and a member of the company’s Executive Management team. Before taking up his current position, John was Medivir’s Director of Clinical R&D. Prior to joining Medivir, John was senior director of Experimental Medicine at Shire based in Nyon, Switzerland. Between 2007 and 2012, Dr. Öhd held several positions of increasing responsibility at AstraZeneca in Södertalje, Sweden.